Literature DB >> 10514375

A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats.

D Salvemini1, Z Q Wang, J L Zweier, A Samouilov, H Macarthur, T P Misko, M G Currie, S Cuzzocrea, J A Sikorski, D P Riley.   

Abstract

Many human diseases are associated with the overproduction of oxygen free radicals that inflict cell damage. A manganese(II) complex with a bis(cyclohexylpyridine)-substituted macrocyclic ligand (M40403) was designed to be a functional mimic of the superoxide dismutase (SOD) enzymes that normally remove these radicals. M40403 had high catalytic SOD activity and was chemically and biologically stable in vivo. Injection of M40403 into rat models of inflammation and ischemia-reperfusion injury protected the animals against tissue damage. Such mimics may result in better clinical therapies for diseases mediated by superoxide radicals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514375     DOI: 10.1126/science.286.5438.304

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  89 in total

1.  Neuroprotection against superoxide anion radical by metallocorroles in cellular and murine models of optic neuropathy.

Authors:  Akiyasu Kanamori; Maria-Magdalena Catrinescu; Atif Mahammed; Zeev Gross; Leonard A Levin
Journal:  J Neurochem       Date:  2010-04-29       Impact factor: 5.372

Review 2.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

Review 3.  On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Dennis P Riley; Jay L Zweier; Christoph Thiemermann; Zhi-Qiang Wang; Daniela Salvemini
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 4.  The yin/yang of superoxide dismutase mimetics: potential cardiovascular therapies?

Authors:  David S Weber; Kathy K Griendling
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 5.  Oxidative stress and diabetic complications.

Authors:  Ferdinando Giacco; Michael Brownlee
Journal:  Circ Res       Date:  2010-10-29       Impact factor: 17.367

Review 6.  Redox regulation of neuronal voltage-gated calcium channels.

Authors:  Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Antioxid Redox Signal       Date:  2013-10-25       Impact factor: 8.401

Review 7.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

Review 8.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

9.  Persistent facial pain increases superoxide anion production in the spinal trigeminal nucleus.

Authors:  Emanuela Viggiano; Marcellino Monda; Alessandro Viggiano; Andrea Viggiano; Caterina Aurilio; Bruno De Luca
Journal:  Mol Cell Biochem       Date:  2010-01-08       Impact factor: 3.396

10.  Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways.

Authors:  Ines Batinić-Haberle; Michael M Ndengele; Salvatore Cuzzocrea; Júlio S Rebouças; Ivan Spasojević; Daniela Salvemini
Journal:  Free Radic Biol Med       Date:  2008-10-17       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.